Evidence map›Paper›PMID 35341220›Full record

ArticlePolymer chemistry2022

A disulfide-based linker for thiol-norbornene conjugation: formation and cleavage of hydrogels by the use of light.

Markus Lunzer, Boris Maryasin, Tommaso Zandrini, Stefan Baudis, Aleksandr Ovsianikov, Robert Liska

Open access · hybridAbstract read
In one paragraph

Article in Polymer chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Synthetic living materials in cancer biology.Nature reviews bioengineering · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Markus LunzerInstitute of Applied Synthetic Chemistry, Technische Universität Wien Getreidemarkt 9/E163 1060 Vienna Austria robert.liska@tuwien.ac.at.ORCID https://orcid.org/0000-0002-8052-6517
Boris MaryasinInstitute of Organic Chemistry, University of Vienna Währinger Strasse 38 1090 Vienna Austria.ORCID https://orcid.org/0000-0001-7943-7333
Tommaso ZandriniInstitute of Materials Science and Technology, Technische Universität Wien Getreidemarkt 9/E308 1060 Vienna Austria.ORCID https://orcid.org/0000-0003-3851-4675
Stefan BaudisInstitute of Applied Synthetic Chemistry, Technische Universität Wien Getreidemarkt 9/E163 1060 Vienna Austria robert.liska@tuwien.ac.at.ORCID https://orcid.org/0000-0002-5390-0761
Aleksandr OvsianikovInstitute of Materials Science and Technology, Technische Universität Wien Getreidemarkt 9/E308 1060 Vienna Austria.ORCID https://orcid.org/0000-0001-5846-0198
Robert LiskaInstitute of Applied Synthetic Chemistry, Technische Universität Wien Getreidemarkt 9/E163 1060 Vienna Austria robert.liska@tuwien.ac.at.ORCID https://orcid.org/0000-0001-7865-1936
TU Wien · ATUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photolabile groups are the key components of photo-responsive polymers, dynamically tunable materials with multiple applications in materials and life sciences. They usually consist of a chromophore and a labile bond and are inherently light sensitive. An exception are disulfides, simple reversible linkages, which become photocleavable upon addition of a photoinitiator. Despite their practical features, disulfides are rarely utilized due to their impractical formation. Here, we report a disulfide-based linker series bearing norbornene terminals for facile crosslinking of thiol-functionalized macromers

Identifiers

PMID35341220
PMCPMC8886483
OpenAlexW4205454251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.